Subgroup within dataset | Dataset | |||||
---|---|---|---|---|---|---|
RCTs for HT | RCT for diet | WHI OS | ||||
MI HR for HT in the subgroup of the indicated dataset (Numbers in parentheses are HRs for E+P and E-alone) | ||||||
95% CI | 95% CI | 95% CI | ||||
All participants | 1.18 (1.30,1.05) | 0.99 to 1.41 | 0.75 (0.95,0.65) | 0.62 to 0.89 | 0.83 (0.86, 0.80) | 0.72 to 0.95 |
Age | ||||||
50–59 | 1.25 (1.63,0.69) | 0.80 to 1.96 | 0.57 (0.73,0.44) | 0.37 to 0.89 | 0.73 (0.74,0.60) | 0.54 to 0.99 |
60–69 | 1.01 (1.05,0.95) | 0.78 to 1.32 | 0.73 (0.88,0.65) | 0.56 to 0.94 | 0.87 (0.97,0.81) | 0.71 to 1.07 |
70–79 | 1.46 (1.46,1.20) | 0.99 to 2.15 | 0.87 (1.33,0.74) | 0.65 to 1.18 | 0.84 (0.75,0.86) | 0.68 to 1.03 |
Years since meno | ||||||
<10 | 1.03 (1.14,0.77) | 0.73 to 1.46 | 0.83 (1.01,0.68) | 0.60 to 1.15 | 0.85 (0.94,0.80) | 0.73 to 0.99 |
10–19 | 0.95 (1.06,0.74) | 0.68 to 1.34 | 0.67 (0.95,0.47) | 0.48 to 0.95 | 0.77 (0.74,0.72) | 0.44 to1.35 |
>19 | 1.41 (1.77,1.23) | 1.08 to 1.85 | 0.69 (0.60,0.70) | 0.50 to 0.93 | 1.35 (0.61,1.28) | 0.46 to 3.96 |
HT after baseline | No data | 0.71 (0.76, 0.72) | 0.57 to 0.88 | |||
Follow-up for RCT | ||||||
End 3 years after enrolment | 1.26 (1.45,1.06) | 1.00 to 1.58 | 0.86 (0.87,0.85) | 0.71 to 1.02 | ||
Begin 3 years after enrolment | 1.08 (1.11,1.04) | 0.82 to 1.41 | 0.79 (0.84,0.73) | 0.64 to 0.97 | ||
Previous use of HT | ||||||
No | 1.07 (0.96,1.20) | 0.86 to 1.32 | ||||
Yes | 1.51 (1.12,1.46) | 1.09 to 2.08 | ||||
Propensity score | ||||||
<0.25 | 1.26 (1.27,1.18) | 0.96 to 1.66 | 0.75 (0.76, 0.71) | 0.48 to 1.17 | 0.98 (1.04,0.83) | 0.72 to 1.34 |
0.25–0.75 | 1.11 (1.32,1.02) | 0.87 to 1.42 | 0.80 (1.01, 0.69) | 0.64 to 1.00 | 0.85 (0.81, 0.86) | 0.72 to 1.01 |
>0.75 | 1.05 (NA, 0.93) | 0.42 to 2.64 | 0.69 (1.08, 0.67) | 0.34 to 1.40 | 0.76 (0.96, 0.74) | 0.45 to 1.27 |
E-alone, oestrogen alone; E+P, oestrogen plus progestin; HT, hormone therapy; meno, menopause; MI, myocardial infarction; NA, not available because only one MI case in this group; OS, observational study; RCT, randomised controlled trial; WHI, Women's Health Initiative.